Compare Guardant Health Inc. Common Stock (GH) vs Huntington Ingalls Industries Inc (HII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Guardant Health Inc. Common Stock vs Huntington Ingalls Industries Inc — how do they compare? Guardant Health Inc. Common Stock trades at $165.58 (market cap $22.58B), while Huntington Ingalls Industries Inc trades at $265 (market cap $10.27B). The key difference: Guardant Health Inc. Common Stock is far larger — about 2.2× Huntington Ingalls Industries Inc's market cap, and Huntington Ingalls Industries Inc pays a 2.12% dividend while Guardant Health Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Guardant Health Inc. Common Stock for 0 Days and Huntington Ingalls Industries Inc for 28 Days on average.
| GH | HII | |
|---|---|---|
Market Cap | $22.58B | $10.27B |
Volume | 2,200,599 | 554,386 |
Sector | Health | Industrials |
52-Week High | $187.22 | $453.73 |
52-Week Low | $61.73 | $257.05 |
Typical Hold Time | 0 Days | 28 Days |
Enterprise Value | $23.22B | $13.19B |
Dividend Yield | — | 2.12% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
HII trades at $260.67, down 1.17% on the day, amid a bearish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $5.27 exceeding expectations. Recent news highlights contract wins, including a $5.1 billion aircraft carrier overhaul and expansion in unmanned systems, supporting a $57.3 billion backlog. Valuation ratios appear reasonable with a P/E of 15.53 and P/S of 0.78.
The outlook is supported by robust defense budgets and contract momentum, but risks include execution on large projects and market sentiment. Analysts are mixed with a 40.7% buy rating and a consensus price target of $363.67, suggesting significant upside potential from current levels if operational performance continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Guardant Health Inc. Common Stock
Guardant Health develops blood tests for cancer care. Its tests support genomic profiling, cancer screening, recurrence monitoring, and treatment decisions.
Read more on GH →About Huntington Ingalls Industries Inc
Huntington Ingalls is the largest military shipbuilder in the U.S. and a provider of professional services to government and industry partners, specializing in nuclear-powered submarines and aircraft carriers.
Read more on HII →
